Omega Protein Corp

Omega Protein — Investor Presentation (May 2014)

25 slides from Omega Protein's investor presentation, May 21, 2014

  1. Slide 1: Investor Presentation May 2014

    OMEGA Qe PROTEIN’ Healthy Products for a Healthy World® Investor Presentation May 2014

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements The statements contained in this presentation that are not historical facts are forward-looking statements that involve number of risks and uncertainties. Forward-looking information may be based on projections, predictions and estimates. Some statements in this presentati

  3. Slide 3: Omega Protein Key Facts

    Omega Protein KEY FACTS * — Nutritional product company—focused on specialty proteins, lipids, and nutraceuticals * — Serving the Human and Animal Nutrition Industries * Leading vertically integrated producer of Omega-3 fish oils and specialty protein products + 5 manufacturing facilities and 30+ fi

  4. Slide 4: Product Mix & Customers

    Product Mix & Customers 2013 Revenue by Product & Segment ME Protein ME tipi Mother OMEGA PROTEIN ANIMAL NUTRITION: 87% HUMAN NUTRITION: 13% PROTEIN FISH Ol OMEGA-3 FISH MEAL, ‘SPECIALTY PROTEIN NUTRACEUTICAL WE Shaklee Perigo _ sess Vie Sample Customers OMEGA: sees 5 PROTEIN’ source: omega Protein

  5. Slide 5: Locations and Distribution

    Locations and Distribution LOCAL PRODUCTION & OPERATIONS GLOBAL DISTRIBUTION , % of 2013 SALES Latin America Beau ' ESPORTS ee - 49% |™ > FOQMEGA | , :

  6. Slide 6: Strategic Business Model

    Strategic Business Model CORPORATE VALUE ay PROPOSITION Sy) INTEGRATED mmKemt MODEL OMEGA re PROTEIN’

  7. Slide 7: Strategic Growth Objectives

    Strategic Growth Objectives OMEGA PROTEIN’ ) Y New Products v Improve ¥ Grow Sales & & Operating & Capture Market Capabilities Capital Efficiency Share Y Increase v Decrease Profits & Cash Earnings Volatility ¥ Create Shareholder Value

  8. Slide 8: Track Record of Growth

    Track Record of Growth Revenues from Human Nutrition GROWTH through Acquisitions & Organic Investment im i: ee nvestmen 2010 2011 2012 2013 CYVEX A\ D> @ & ® OMBGAL o, seeeeeeeeeeeees PROTEIN?” source: omegePratein

  9. Slide 9: Animal Nutrition

    FOOMEGA PROTEIN’ Animal Nutrition

  10. Slide 10: Animal Nutrition Business Drivers

    Animal Nutrition Business Drivers Si2e @ Growing world prope 53 61 68 7.2 population year 1990 2000 «2010 -—S«-2015e ® Growing demand for pork @ Global supply of fish meal and fish oil World Pig Meat Production (thousand MT) Global Fish Meal Production 5354 6084 6038 569 5519 5,587 5.019 4,838 4.560

  11. Slide 11: Animal Nutrition

    Animal Nutrition 2013 End Usage Of Fish Meal (volume) PROTEIN Protein ingredient for aquatic/animal feed DAIRY. AQUACULTURE SWINE Considered a premium protein source due to digestibility and aminoacid profile FISH MEAL 2013 End Usage Of Fish Oil (volume) OTHER LIPIDS Fat components of an animal's di

  12. Slide 12: Human Nutrition

    autegrity Human Nutrition

  13. Slide 13: Human Nutrition Business Drivers

    Human Nutrition Business Drivers es nutegrity Growing world en 53 61 68 7.2 population year 1990 2000 2010 2015e 3) Increasing standards of living GP Bischeatthcare costs Developing Countries GDP per Capita employer eee contribution cae mworker contribution S00 Sit 2003 2013 Aging Interest in preven

  14. Slide 14: Human Nutrition

    Human Nutrition Sa. nutegrity PROTEIN Dairy Proteins for dietary supplements & functional foods CUSTOMERS Ingredients and branded Supplement manufacturers products Contract manufacturers LIPIDS Functional food markets Fish oil for dietary supplements & functional foods Available in a variety of ) OP

  15. Slide 15: OMEGA

    OMEGA OMSK.

  16. Slide 16: Income Statement Highlights

    Income Statement Highlights REVENUE 2009-2013 Million US. $ a $236 $244 Strong industry fundamentals yield healthy ron atk margins over time Seasonal factors can create short-term volatility, especially in Animal segment 009 oo10 coi coi coi Strong cash flow generation Animal Human GROSS MARGIN 2009

  17. Slide 17: Balance Sheet Highlights

    Balance Sheet Highlights CASH BALANCE 2009-2013 DEBT BALANCE 2009-2013 Million US. $ Million US. $ $2 2009 2010 2011 2012 2013 2009 2010 2011 2012 2013 “*Debtincludes capital leases Strong Balance Sheet and Ample Liquidity provide Financial Flexibility to: * Execute growth strategy OMEGA ROOMEGA

  18. Slide 18: Investment Highlights

    Investment Highlights STRONG GROWTH POTENTIAL AND FOCUS ON INCREASED SHAREHOLDER VALUE Strategic Investments and Product/Market Expansion Increasing Demand for Animal Nutrition Ingredients & Stable Global Fish Supply OMEGA, nn ROOMEGA

  19. Slide 19: $ OMEGA

    $ OMEGA Ss PROTEIN’

  20. Slide 20: Omega Protein Gross Profit Drivers

    Omega Protein Gross Profit Drivers Animal Segment > Gross Profit 4 $77.1M 36.2% of reverues 5 Omega Protein Consolidated Gross Profit $82.8M 33.9% of reverues Human Segment Gross Profit Z $5.7M 18.2% of revenues 2013 ResultsDisplayed OMEGA ae ROOMEGA 19

  21. Slide 21: Animal Nutrition Gross Profit Drivers

    Animal Nutrition Gross Profit Drivers REVENUE PER TON $1,455 = Forward Contracting 7 REVENUE = Product Mix SALES Animal VOLUME pias | Segment $213.2M KE * Production Catch estita $77.1M 5 Held COST OF $136.1M 36.2% oF r _ = Inventory Carryover SALES ¥ COST PER $867 TON Legend = Catch 2013Results = Y

  22. Slide 22: Human Nutrition Gross Profit Drivers

    Human Nutrition Gross Profit Drivers REVENUE Omega-3 Sales Whey Protein Sales Other Nutraceutical Sales Tolling Revenues GROSS MARGIN % OMEGA PROTEIN Production Costs Capacity Utilization Market Prices Product Mix $31.1M 18.2% Human Segment Gross Profit

  23. Slide 23: Key Historical Drivers

    Key Historical Drivers 2009 2010 2011 2012 2013 Financial Drivers ‘a FishCatch (short tons) 69,067 473,857 602,062 578,392 485,626 Implied Total View 38.4% 37.0% 34.5% 33.6% 39.2% 0 Total Production (tons) 180,109 175,468 207,763 194,197 190,146 (0) Volumesold 208,488 361781 223,969 202,17 157,313 ©

  24. Slide 24: Regulation G Reconciliation

    Regulation G Reconciliation The following table provides a reconciliation of Adjusted EBITDA*, a non-GAAP (Generally Accepted Accounting Principles) financial measure, to net income, the most directly comparable financial measure calculated and presented in accordance with GAAP, for fiscal years end

  25. Slide 25: Regulation G Reconciliation

    Regulation G Reconciliation *Adjusted EBITDA represents net income before interest expense, income tax, depreciation and amortization, investigation charge, net loss on disposal of assets, and the 2011 Gulf Coast Claims Facility (Deepwater Horizon claim) and 2008 and 2005 hurricane litigation settle

Omega Protein — Investor Presentation (May 2014) on 6ix